Pfizer has officially submitted its request to the Food and Drug Administration (FDA) to clear its COVID-19 vaccine for emergency use in children under the age of five.
The pharmaceutical giant, along with BioNTech SE, finalized their application with the FDA for emergency use authorization (EUA) of their vaccine in children aged six months to four years. In a statement on Wednesday, the companies said that they began the submission process in February.
Pfizer announced in May that a three-shot regimen was highly effective and prompted a robust immune response in children under age 5. Pfizer’s data was based on early results from a highly anticipated trial that is likely to pave the way for infants and toddlers to be immunized.
Early testing found that the vaccine was 80.3% effective in preventing COVID infections among young children, with ten infections occurring among all study participants. According to the company, the final results will be determined once 21 children enrolled in the study have been infected.
In February, Pfizer launched a rolling review of data from the trial of 1,678 children under the age of 5. The three-dose vaccine regimen was well-tolerated, with a safety profile similar to that of the placebo, and most […]
The post Aiming To Jab The Nation’s Youngest, Pfizer Makes Submission For COVID-19 Vaccination Emergency Authorization For Kids Under 5 appeared first on NOQ Report – Conservative Christian News, Opinions, and Quotes.
Click this link for the original source of this article.
Author: The Gateway Pundit
This content is courtesy of, and owned and copyrighted by, https://noqreport.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.